Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 54.9B | 55.3B | 52.3B | 59.7B |
| Cost of revenue | 52.8B | 53.3B | 50.4B | 57.9B |
| Gross profit | 2.1B | 1.9B | 1.9B | 1.9B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 1.3B | 1.3B | 1.3B | 1.2B |
| Other operating expenses | — | — | — | — |
| Operating income | 656M | 530M | 551M | 538M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 74M | 35M | 32M | -4M |
| Other income expense | 83M | 16M | 22M | -146M |
| Pretax income | 665M | 511M | 541M | 396M |
| Tax provision | 157M | 110M | 124M | 162M |
| Net income | 508M | 401M | 417M | 234M |
| Basic EPS | 2.1 | 1.7 | 1.7 | 1.0 |
| Diluted EPS | 2.1 | 1.7 | 1.7 | 1.0 |
| Basic average shares | 240M | 242M | 243M | 244M |
| Diluted average shares | 241M | 243M | 245M | 245M |
| EBITDA | 872M | 719M | 738M | 708M |
| Net income from continuing op. | 508M | 401M | 417M | 234M |
| Minority interests | -2M | -1M | -1M | 2M |
| Preferred stock dividends | — | — | — | — |